{"lastClose": 5.929999828338623, "len": 1068, "date": "2023-01-09", "alpha_1": -0.05540483195920254, "beta_1": 1.6270955433373664, "drawup_1": 1.5486725887776869, "natr_1": 15.515179382240648, "sup_1": -0.5008430958306284, "res_1": 0.09443517618436631, "bullPattern_1": ["HIGHWAVE", "SPINNINGTOP"], "bearPattern_1": [], "rsi_1": 23.11160760004376, "adx_1": 66.25668689305893, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.6956776193995027, "stratHoldAlpha_1": 250.5283627408864, "stratHoldDrawdown_1": -0.6210202588963241, "alpha_3mo": -0.9319861474419451, "beta_3mo": 1.5183333130583478, "drawup_3mo": 0.22945207492744557, "natr_3mo": 15.515179382240648, "sup_3mo": -0.23777398470202363, "res_3mo": 0.22428335246176767, "bullPattern_3mo": [], "bearPattern_3mo": ["BELTHOLD", "CLOSINGMARUBOZU", "LONGLINE", "MARUBOZU"], "rsi_3mo": 33.55704676508394, "adx_3mo": 27.93644722265042, "drawdown_3mo": -0.4881602805227039, "stratHoldSharpe_3mo": -3.6590061190868335, "stratHoldAlpha_3mo": 248.89238188662782, "stratHoldDrawdown_3mo": -0.4393442524704335, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 853003061, "IPO Year": 2018.0, "Name": "Allogene Therapeutics Inc.", "Country": "United States", "alpha%_1": 0.6205554977781319, "beta%_1": 0.8961196789645123, "drawup%_1": 0.9995040201536282, "natr%_1": 0.9999969908020054, "drawdown%_1": 0.08495956109609432, "stratHoldSharpe%_1": 0.21952944406914865, "stratHoldAlpha%_1": 0.07060927419286034, "stratHoldDrawdown%_1": 0.07983186484081228, "alpha%_3mo": 0.06534279134502827, "beta%_3mo": 0.8531366571449845, "drawup%_3mo": 0.43950820221102493, "natr%_3mo": 0.9999961707779507, "drawdown%_3mo": 0.001112899974910274, "stratHoldSharpe%_3mo": 0.0026136142832440382, "stratHoldAlpha%_3mo": 3.862955003444219e-05, "stratHoldDrawdown%_3mo": 0.001354292348788657}